Apolipoprotein A II/APOA2 Monoklonaler Antikörper

Apolipoprotein A II/APOA2 Monoklonal Antikörper für WB, IHC, Indirect ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

human

Anwendung

WB, IHC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1G1A2

Kat-Nr. : 66773-1-PBS

Synonyme

APOA2, apolipoprotein A II, ApoA-II, Apo-AII, ApoA II



Geprüfte Anwendungen

Produktinformation

66773-1-PBS bindet in WB, IHC, Indirect ELISA Apolipoprotein A II/APOA2 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen Apolipoprotein A II/APOA2 fusion protein Ag9863
Vollständiger Name apolipoprotein A-II
Berechnetes Molekulargewicht 100 aa, 11 kDa
Beobachtetes Molekulargewicht 8-11 kDa
GenBank-ZugangsnummerBC005282
Gene symbol APOA2
Gene ID (NCBI) 336
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Apolipoprotein A-II (APOA2) is a major component of high density lipoprotein (HDL) and it plays an important role in directing the fate of lipid metabolism among HDL. It is primarily synthesized by liver. The predicted MW of ApoA2 is 11 kDa, while the mature form is smaller (7-10 kDa) since the signal peptide was cleaved. In humans, most of circulating apoA2 exist as dimer. Five types of APOA2 dimer exist: homodimer apoA2-ATQ/ATQ, heterodimer apoA2-ATQ/AT, homodimer apoA2-AT/AT, apoA2-AT/A, and apoA2-A/A. ApoA2 isoforms are considered to be some of the most promising serum/plasma biomarkers for aiding the early detection of pancreatic cancer. (PMID: 29081441, 29481802)